Cerebricon is the world’s premier contract research organization (CRO) in the area of specialized and focused preclinical models for CNS and PNS. Cerebricon preclinical models include models for neurology, psychiatry, biomarkers and biomedical imaging.
All models are performed in Cerebricon’s proprietal laboratories by its permanent staff of scientists and technicians. Cerebricon’s preclinical platform includes in vivo small animal models, in vitro cell culture models, behavioural laboratories, small animal imaging (MRI) services, radiolabelling and SPECT as well as histology and immunohistochemistry services.
Cerebricon’s fully validated preclinical models include preclinical surgical models and mouse transgenic models for neurology:
All routes of administration have been validated for ip, sc, po, im, iv, ic, intrathecal, intranasal, osmotic minipumps, diets and drinking water.
Either alone or in conjunction with the above in vivo assays, Cerebricon’s staff of behavioural scientists and technicians has fully validated preclinical behavioural models for neurology and psychiatry. Cerebricon has preclinical models for cognition, preclinical models for function and preclinical models for behaviour for naïve rats and mice, and aged rats and aged mice. Cerebricon also has transgenic disease models and surgical and chemically induced preclinical models.
Tests for cognition:
Sensory motor tests:
Anxiety and depression:
Behavioural phenotyping:
Cerebricon has its own 7.0 Tesla small animal MRI. Cerebricon uses this to employ the following techniques for the preclinical study of compounds aimed at CNS and PNS diseases and also biomarkers:
Cerebricon also employs SPECT scanning and routinely carries out radiolabelling for client compounds.
Cerebricon’s in vitro laboratories perform rodent primary cell culture models and provide high throughput screening of compounds for neurotoxicity, neuroprotection and neurite outgrowth (NOG). In addition, more comprehensive and concentrated studies of compound mechanism of action are regularly performed in our in vitro laboratories.
Cultures can be exposed to glutamate, NMDA, kainate, oxygen glucose deprivation (OGD), H2O2, Aß (beta amyloid), LPS, KCL and 6-OHDA.
Cerebricon also has in-house histology and immunohistochemistry services.
Cerebricon Ltd
Microkatu 1
Kuopio
70211
Finland
Tel: +358 17 3680 801
Fax: +358 17 3680 803
Email:
info@cerebricon.com
Email:
patrick.sweeney@cerebricon.com
URL:
www.cerebricon.com/DowebEasyCMS/Sivusto/Dokumentit/White%20Paper%2004-08.pdf
URL:
www.cerebricon.com